Connection

Shinyu Izumi to Biomarkers

Back to Details
This is a "connection" page, showing publications Shinyu Izumi has written about Biomarkers.
Shinyu Izumi
Connection Strength
0.070
Biomarkers
  1. Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene. 2021 Jan 15; 766:145145.
    View in: PubMed
    Score: 0.041
  2. Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid. Respir Investig. 2021 May; 59(3):377-381.
    View in: PubMed
    Score: 0.010
  3. Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19. J Clin Apher. 2021 Jun; 36(3):313-321.
    View in: PubMed
    Score: 0.010
  4. Markers of Disease Severity in Patients with Spanish Influenza in the Japanese Armed Forces, 1919-1920. Emerg Infect Dis. 2017 04; 23(4):662-664.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.